PCV38 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PROPHYLAXIS AFTER TOTAL HIP OR TOTAL KNEE REPLACEMENT IN KOREA
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)73800-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)73800-6/fulltext
Section Title :
Section Order :
263
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73800-6&doi=10.1016/S1098-3015(10)73800-6